We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$228B
AUM Growth
-$15.4B
Cap. Flow
-$1.28B
Cap. Flow %
-0.56%
Top 10 Hldgs %
13.8%
Holding
11,885
New
1,174
Increased
4,828
Reduced
3,849
Closed
1,024

Sector Composition

Rank Sector Weight
1 Technology 10.88%
2 Financials 6.67%
3 Healthcare 6.52%
4 Consumer Discretionary 4.99%
5 Industrials 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOB
8851
Mobilicom Ltd
MOB
$71.9M
$7K ﹤0.01%
+4,053
New +$9.37K
MXE
8852
Mexico Equity and Income Fund
MXE
$59.3M
$7K ﹤0.01%
883
NA
8853
Nano Labs
NA
$44.3M
$7K ﹤0.01%
+429
New +$25.9K
NBN icon
8854
Northeast Bank
NBN
$1.16B
$7K ﹤0.01%
+180
New +$7.07K
NCSM icon
8855
NCS Multistage Holdings
NCSM
$126M
$7K ﹤0.01%
335
-133
-28% -$3.82K
NCTY
8856
The9 Ltd
NCTY
$72.7M
$7K ﹤0.01%
682
-2,718
-80% -$38.8K
OLMA icon
8857
Olema Pharmaceuticals
OLMA
$1.02B
$7K ﹤0.01%
+2,431
New +$10.3K
PALC icon
8858
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$219M
$7K ﹤0.01%
229
+86
+60% +$3.07K
PHAT icon
8859
Phathom Pharmaceuticals
PHAT
$684M
$7K ﹤0.01%
+628
New +$5.98K
PROK icon
8860
ProKidney
PROK
$330M
$7K ﹤0.01%
793
-713
-47% -$6.2K
PSTV
8861
DELISTED
Plus Therapeutics
PSTV
$7K ﹤0.01%
43
+6
+16% +$1.34K
REPX icon
8862
Riley Exploration Permian
REPX
$727M
$7K ﹤0.01%
359
+105
+41% +$2.57K
RITA icon
8863
ETFB Green SRI REITs ETF
RITA
$9.72M
$7K ﹤0.01%
399
-371
-48% -$7.51K
RMTI icon
8864
Rockwell Medical
RMTI
$29.3M
$7K ﹤0.01%
577
+568
+6,311% +$8.6K
RSSS icon
8865
Research Solutions
RSSS
$75.6M
$7K ﹤0.01%
3,623
-1,078
-23% -$2.01K
SEIX icon
8866
Virtus SEIX Senior Loan ETF
SEIX
$252M
$7K ﹤0.01%
+284
New +$6.68K
SISI
8867
DELISTED
Shineco
SISI
$7K ﹤0.01%
+1
New +$11.6K
SRI icon
8868
Stoneridge
SRI
$212M
$7K ﹤0.01%
436
-161
-27% -$3.02K
SSKN
8869
DELISTED
Strata Skin Sciences
SSKN
$7K ﹤0.01%
798
-403
-34% -$4.09K
SVOL icon
8870
Simplify Volatility Premium ETF
SVOL
$521M
$7K ﹤0.01%
+337
New +$7.61K
TDV icon
8871
ProShares S&P Technology Dividend Aristocrats ETF
TDV
$278M
$7K ﹤0.01%
+137
New +$7.78K
TOI icon
8872
The Oncology Institute
TOI
$513M
$7K ﹤0.01%
1,584
+1,071
+209% +$6.3K
TOVX icon
8873
Theriva Biologics
TOVX
$10.6M
$7K ﹤0.01%
271
+255
+1,594% +$9.79K
TRVI icon
8874
Trevi Therapeutics
TRVI
$2.65B
$7K ﹤0.01%
4,277
-494
-10% -$1.62K
TSPA icon
8875
T. Rowe Price US Equity Research ETF
TSPA
$4.38B
$7K ﹤0.01%
+310
New +$7.38K

Similar funds

UBS Group's Q3 2022 Portfolio in Review

As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q3 2022 filing shows 1,174 new, 4,828 increased, 3,849 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
  • UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
  • UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
  • UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
  • UBS Group opened 1,174 new positions and closed 1,024 in Q3 2022.
  • UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.

Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.